Rex Chisholm, PhD, vice dean of Scientific Affairs and Graduate Education, co-authored two recent papers that used electronic health records to explore patient genetic data, including genes inherited from early humans.
Menu
Browsing: Clinical Breakthroughs
A landmark national study has shown allowing surgical residents the flexibility to work longer hours does not pose any greater risk to patients.
A phase III clinical trial including Northwestern Medicine investigator Steven Flamm, MD, tested a new combination of antiviral drugs for hepatitis C patients with late-stage cirrhosis.
Patients with a specific type of heart failure were less active when taking a commonly prescribed nitrate medication thought to improve exercise capacity, according to a recent study co-authored by Northwestern Medicine investigator Sanjiv Shah, MD.
Five recipients receive seven organs from a single donor, all over the course of 34 hours.
A randomized clinical trial showed an intravitreous drug may be an alternative treatment for some patients with proliferative diabetic retinopathy.
Injections of botulinum toxin improved active arm movement for stroke and brain trauma patients in a clinical trial that involved Northwestern Medicine co-investigator Christina Marciniak, MD, ’85 GME.
Children with allergic disease have about twice the rate of high blood pressure and high cholesterol, according to a new Northwestern Medicine study.
Karl Bilimoria, MD, director of the Northwestern Surgical Outcomes and Quality Improvement Center, discusses his team’s research to elevate the quality of care patients receive.
A clinical trial led by Northwestern Medicine scientist Mihai Gheorghiade, MD, opens the door for further investigation of a new drug to treat the more than one million patients in the United States hospitalized for heart failure every year.